a:5:{s:8:"template";s:9852:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0" name="viewport">
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Roboto%3A400%2C600%2C700%7CRoboto+Condensed%3A400%2C600%2C700%7COpen+Sans%3A400%2C600%2C700&amp;ver=4.9.4" id="dt-web-fonts-css" media="all" rel="stylesheet" type="text/css">
<style rel="stylesheet" type="text/css">@charset "utf-8"; .masthead{position:relative;z-index:102}.masthead:not(.side-header){display:-ms-flexbox;-ms-flex-direction:column}.main-nav>li>a{text-decoration:none}.main-nav>li,.main-nav>li>a{display:-webkit-flex;display:-moz-flex;display:-ms-flexbox;display:-ms-flex;position:relative}.main-nav>li{display:flex}.main-nav>li>a{display:flex;-webkit-align-items:center;-moz-align-items:center;-ms-align-items:center;-ms-flex-align:center;align-items:center}.main-nav .menu-item a .fa,.main-nav .menu-item a>i{padding-right:6px}.menu-text{display:block}.top-header .main-nav .menu-text:after{position:absolute;top:50%;margin-top:-5px;right:0;width:8px;height:8px;content:""}.masthead:not(.side-header) .header-bar{-webkit-align-content:stretch;-moz-align-content:stretch;-ms-align-content:stretch}.dt-close-mobile-menu-icon{position:fixed;top:0;width:30px;height:30px;left:-50px;z-index:9999;opacity:0;-webkit-transition:opacity .2s ease;transition:opacity .2s ease;-webkit-transition-delay:.5s;transition-delay:.5s}.dt-close-mobile-menu-icon span{position:relative;display:block;width:30px;height:30px;margin:0}.dt-close-mobile-menu-icon span:hover{cursor:pointer}.dt-close-mobile-menu-icon span:after,.dt-close-mobile-menu-icon span:before{display:inline-block;height:2px;background:#fff;position:absolute;content:'';-webkit-transform-origin:50% 50%;transform-origin:50% 50%;top:50%;left:50%;margin:-1px 0 0 -11px;width:22px;-webkit-transition:-webkit-transform .1s ease;transition:transform .1s ease}.dt-close-mobile-menu-icon span:before{-ms-transform:rotate3d(0,0,1,45deg);-webkit-transform:rotate3d(0,0,1,45deg);transform:rotate3d(0,0,1,45deg)}.dt-close-mobile-menu-icon:hover span:before{-ms-transform:rotate3d(0,0,1,0deg);-webkit-transform:rotate3d(0,0,1,0deg);transform:rotate3d(0,0,1,0deg)}.dt-close-mobile-menu-icon span:after{-ms-transform:rotate3d(0,0,1,-45deg);-webkit-transform:rotate3d(0,0,1,-45deg);transform:rotate3d(0,0,1,-45deg)}.dt-close-mobile-menu-icon:hover span:after{-ms-transform:rotate3d(0,0,1,0deg);-webkit-transform:rotate3d(0,0,1,0deg);transform:rotate3d(0,0,1,0deg)}/*! Horizontal headers */.masthead:not(.side-header){max-width:1200px;margin:0 auto}@media all and (-ms-high-contrast:none),(-ms-high-contrast:active){.masthead:not(.side-header):not(.mixed-header){display:-ms-flexbox;-ms-flex-direction:column;-webkit-align-content:space-between;-moz-align-content:space-between;-ms-align-content:space-between;align-content:space-between;-webkit-justify-content:center;-moz-justify-content:center;-ms-flex-pack:center;-ms-justify-content:center;justify-content:center}.masthead:not(.side-header):not(.mixed-header) .header-bar{width:100%}}.masthead:not(.side-header) .header-bar{position:relative;display:-webkit-flex;display:-moz-flex;display:-ms-flexbox;display:-ms-flex;display:flex;-webkit-align-items:stretch;-moz-align-items:stretch;-ms-align-items:stretch;-ms-flex-align:stretch;align-items:stretch;align-content:stretch;-ms-flex-line-pack:stretch;-webkit-justify-content:space-between;-moz-justify-content:space-between;-ms-justify-content:space-between;justify-content:space-between;-ms-flex-pack:justify}.masthead:not(.side-header) .main-nav{display:-webkit-flex;display:-moz-flex;display:-ms-flexbox;display:-ms-flex;display:flex;-webkit-flex-flow:row wrap;-moz-flex-flow:row wrap;-ms-flex-flow:row wrap;flex-flow:row wrap;-webkit-align-items:center;-moz-align-items:center;-ms-align-items:center;-ms-flex-align:center;align-items:center}/*! Full height menu */.masthead:not(.side-header) .header-bar .main-nav>li>a{display:-webkit-flex;display:-moz-flex;display:-ms-flexbox;display:-ms-flex;display:flex;-webkit-align-items:center;-moz-align-items:center;-ms-align-items:center;-ms-flex-align:center;align-items:center;-webkit-align-content:center;-moz-align-content:center;-ms-align-content:center;align-content:center;-ms-flex-line-pack:stretch} .load-wrap{background-position:center center;background-repeat:no-repeat}.load-wrap,body #load{width:100%}.load-wrap,body #load{height:100%}body #load{display:block;position:fixed;z-index:9901}.load-wrap{text-align:center;display:-webkit-flex;display:-moz-flex;display:-ms-flexbox;display:-ms-flex;display:flex;-webkit-align-items:center;-moz-align-items:center;-ms-align-items:center;-ms-flex-align:center;align-items:center;-webkit-flex-flow:column wrap;-moz-flex-flow:column wrap;-ms-flex-flow:column wrap;flex-flow:column wrap;-webkit-justify-content:center;-moz-justify-content:center;-ms-flex-pack:center;-ms-justify-content:center;justify-content:center} 
 body,html{font:normal 16px/28px Roboto,Helvetica,Arial,Verdana,sans-serif;word-spacing:normal;color:#666}a,a:hover{color:#ff8000}#main>.wf-wrap{width:1250px}#main{padding:70px 0 70px 0}body{background:#f3f3f3 none repeat fixed center top;background-size:auto}#page{background:#fff none repeat center top;background-size:auto}.masthead:not(.side-header){max-width:100%}.masthead:not(.side-header):not(.full-width):not(.side-header-v-stroke):not(.side-header-menu-icon){padding:0 44px;box-sizing:border-box}.masthead:not(.side-header):not(.side-header-menu-icon) .header-bar{max-width:calc(1250px - 88px);margin:0 auto}.masthead:not(.side-header):not(.mixed-header) .header-bar{min-height:110px}.dt-mobile-header .soc-ico a:not(:hover) .soc-font-icon,.masthead .soc-ico a:not(:hover) .soc-font-icon{color:#ff8000;color:#fff!important;-webkit-text-fill-color:#fff!important;background:0 0!important}.main-nav>li>a{margin:0;padding:10px 10px 10px 10px}.top-header .outside-item-remove-margin.main-nav>li:first-child>a{margin-left:0}.top-header .outside-item-remove-margin.main-nav>li:last-child>a{margin-right:0}.main-nav>li>a .menu-text{font:normal bold 20px/24px "Roboto Condensed",Helvetica,Arial,Verdana,sans-serif;text-transform:uppercase}.main-nav>li:not(.wpml-ls-item)>a .menu-text{color:#2e726c}.main-nav>li:not(.wpml-ls-item)>a{color:#2e726c}.main-nav>li:not(.act):not(.wpml-ls-item)>a:hover .menu-text{color:#ff8000}.main-nav>li:not(.act):not(.wpml-ls-item)>a:hover{color:#ff8000}.main-nav>.menu-item>a .fa{font-size:14px}.dt-close-mobile-menu-icon span{color:#fff;background-color:#ff8000}.masthead:not(.mixed-header){background:#fff none repeat center center;background-size:auto}.masthead.shadow-decoration:not(.side-header-menu-icon):not(#phantom){-webkit-box-shadow:0 0 15px 1px rgba(0,0,0,.07);box-shadow:0 0 15px 1px rgba(0,0,0,.07)}.custom-menu a:not(:hover){color:#222}.sidebar-content .custom-menu a:not(:hover){color:#222}.footer .custom-menu a:not(:hover){color:#222}.sidebar-content .widget:not(.widget_icl_lang_sel_widget) .custom-menu a:not(:hover){color:#222}.sidebar-content .sidebar-content .widget:not(.widget_icl_lang_sel_widget) .custom-menu a:not(:hover){color:#222}.footer .sidebar-content .widget:not(.widget_icl_lang_sel_widget) .custom-menu a:not(:hover){color:#222}@media screen and (min-width:1050px){.phantom-sticky:not(.overlap):not(.transparent) .masthead:not(.side-header){-webkit-transition:background-color 330ms ease;transition:background-color 330ms ease}}@media screen and (max-width:1050px){.masthead .main-nav,.masthead:not(.side-header) .header-bar,.masthead:not(.side-header) .main-nav{display:none}}@media screen and (max-width:500px){.masthead{top:0!important}.masthead:not(.side-header){-webkit-transform:none!important;transform:none!important}}  </style>
</head>
<body class="disabled-hover-icons click-effect-on-img dt-responsive-on overlay-cursor-on srcset-enabled btn-flat custom-btn-color custom-btn-hover-color bold-icons phantom-sticky phantom-shadow-decoration phantom-main-logo-on top-header first-switch-logo-left first-switch-menu-right second-switch-logo-left second-switch-menu-right right-mobile-menu layzr-loading-on popup-message-style wpb-js-composer js-comp-ver-5.4.5 vc_responsive outlined-portfolio-icons album-minuatures-style-2">

<div class="spinner-loader" id="load">
<div class="load-wrap"></div>
</div>
<div id="page">
<h1>{{ keyword }}</h1>
<div class="masthead inline-header right shadow-decoration small-mobile-menu-icon dt-parent-menu-clickable show-device-logo show-mobile-logo" role="banner">
<header class="header-bar">
<ul class="main-nav outside-item-remove-margin" id="primary-menu" role="menu">
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-15219 first"><a data-level="1" href="{{ KEYWORDBYINDEX-ANCHOR 0 }}"><i class="fa fa-home"></i><span class="menu-item-text"><span class="menu-text">Home</span></span></a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-15220"><a data-level="1" href="{{ KEYWORDBYINDEX-ANCHOR 1 }}"><i class="fa fa-users"></i><span class="menu-item-text"><span class="menu-text">About</span></span></a></li>
</ul>
</header>
</div><div class="dt-close-mobile-menu-icon"><span></span></div>
<div class="sidebar-none sidebar-divider-off" id="main">
<div class="main-gradient"></div>
<div class="wf-wrap">
<div class="wf-container-main">
{{ text }}
<br>
{{ links }}
</div>
</div>
</div>
<footer class="footer solid-bg" id="footer">
<div class="full-width-line" id="bottom-bar" role="contentinfo">
<div class="wf-wrap">
<div class="wf-container-bottom">
<div class="wf-table wf-mobile-collapsed">
<div class="wf-td">
<div class="wf-float-left">
{{ keyword }} 2022
</div>
</div>
</div>
</div>
</div>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:25575:"Revenue. ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office . This report focuses on the global Point of Care Testing status, future forecast, growth opportunity, key market and key players. Funded. Bentec Medical peak revenue was $10.0M in 2020. including those for the overall size of the global Point of Care Diagnostics (POCD) market in terms of revenue. Biolife Solutions annual revenue for 2019 was $27.4M, a 38.64% growth from 2018. Your Global Diagnostics Partner SEKISUI Diagnostics is part of the SEKISUI Chemical Co. Ltd. family, and a sister company to SEKISUI Medical. Sekisui Diagnostics , LLC. The &quot;S&quot; in SHIFT stands for sustainable, and the Group is pushing to establish a sustainable business base from the viewpoint of ESG. 560. Product Manager at Sekisui Diagnostics San Diego County . Sekisui Diagnostics, LLC. Segment by Type Immunological Test Pathogen Nucleic Acid Test Segment by Application Hospital . Peak Revenue. Company Description: Sekisui Diagnostics GmbH is located in Darmstadt, Hessen, Germany and is part of the Chemical and Allied Products Merchant Wholesalers Industry. Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue in China Market (2016-2021) &amp; (US$ Million) Table 61. Data Bridge Market Research has recently added a concise research on the Point-Of-Care Diagnostics Market to depict valuable insights related to significant market trends driving the industry. All content is posted anonymously by employees working at Sekisui Diagnostics. After extensive research and analysis, Zippia&#x27;s data science team found the following key financial metrics. Company Description: Sekisui Diagnostics P.E.I. Headquartered in Burlington, MA, USA, Sekisui Diagnostics has annual revenue of $200 million and more than 450 employees worldwide. Company size. Sekisui Diagnostics Revenue in Virus Diagnostics Business (2016-2021) &amp; (US$ Million) Table 113. The Infectious Disease Diagnostics Point of Care Test market revenue was Million USD in 2016, grew to Million USD in 2020, and will reach Million USD in 2026, with a CAGR of during 2020-2026. Most Recent Quarter Revenue. The global LDL Test market size is projected to reach USD 9315.7 million by 2027, from USD 6307.4 million in 2020, at a CAGR of 5.3% during the forecast period. Posted on Jul 5 2021 7:20 AM &quot;The Catalase market research report provides a detailed analysis of regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product . It helps physicians with rapid infectious disease diagnosis at the point of care with increased sensitivity. It is classified as operating in the Surgical &amp; Medical Instrument Manufacturing industry. Glassdoor gives you an inside look at what it&#x27;s like to work at Sekisui Diagnostics, including salaries, reviews, office photos, and more. 2.1 Sekisui Diagnostics 2.1.1 Sekisui Diagnostics Company Profile 2.1.2 Sekisui Diagnostics Helicobacter Pylori (H-Pylori) Non-Invasive Testing Product Specification 2.1.3 Sekisui Diagnostics Helicobacter Pylori (H-Pylori) Non-Invasive Testing Production Capacity, Revenue, Price and Gross Margin (2016-2020) 2.2 Quidel 2.2.1 Quidel Company Profile 501 to 1,000. In December 2017, Sekisui Diagnostics announced to the distribution of the Mesa Biotech Point of molecular care system for Flu A/Flu B. $140.4 M. Employees. Contacts. Sekisui Diagnostics Rapid Virus Diagnostic Test Product Table 112. The Influenza Diagnostics Market is predicted to grow at a CAGR of 6.3% during the forecasting period market is expected to grow from $4.0 billion in 2020 to a value of $5.8 billion in 2026. Published on: March 22, 2018. 2.1 Sekisui Diagnostics 2.1.1 Sekisui Diagnostics Company Profile 2.1.2 Sekisui Diagnostics Helicobacter Pylori (H-Pylori) Non-Invasive Testing Product Specification 2.1.3 Sekisui Diagnostics Helicobacter Pylori (H-Pylori) Non-Invasive Testing Production Capacity, Revenue, Price and Gross Margin (2016-2020) 2.2 Quidel 2.2.1 Quidel Company Profile 11.10.1 Sekisui Diagnostics Company Information. Key Data Information from Secondary Sources. Biotechnology. Alan Long, MD Dermatopathologist, CEO. Headquartered in Burlington, MA, USA, Sekisui Diagnostics has annual revenue of $200 million and more than 450 employees worldwide. 12-10-2021 04:01 PM CET | Advertising, Media Consulting, Marketing Research. United States. Responsible for delivering territory and region revenue targets and marginal profit. 9.2 ASEAN: Point of Care Diagnostics Market Share Analysis by Top 5 Vendors (In Terms of %Revenue, in 2020) 9.3 ASEAN: Competitive Scenario (2018-2021) 9.3.1 Product Launches SEKISUI DIAGNOSTICS (UK) LIMITED has 119 employees at this location and generates $50.38 million in sales (USD). Segment Highlights. Table 179. Sekisui Diagnostics Company Details Table 110. Sekisui Diagnostics is a medium health care company with 650 employees and an annual revenue of $136.1M that is headquartered in Massachusetts. Compare company information. Retail Vitamins, Supplements &amp; Health Stores . Quidel&#x27;s peak quarterly revenue was $476.1M in 2020 (Q3). 11.1 Sekisui Diagnostics 11.1.1 Sekisui Diagnostics Company Details 11.1.2 Sekisui Diagnostics Business Overview 11.1.3 Sekisui Diagnostics LDL Test Introduction 11.1.4 Sekisui Diagnostics Revenue in LDL Test Business (2016-2021) 11.1.5 Sekisui Diagnostics Recent Development 11.2 XpressBio 11.2.1 XpressBio Company Details 11.2.2 XpressBio . New Jersey, United States,- The GAS Pharyngitis Diagnostics Market report provides vital information that prepares market players to give fierce competition to their toughest competitors based on growth, sales, and revenue, among other essential factors. Table 109. Sekisui Diagnostics . Quidel has 1,500 employees, and the revenue per employee ratio is $356,593.33. Sekisui Diagnostics&#x27;s annual revenues are $10-$50 million (see exact revenue data) and has 100-500 employees. change. The emergence of wearable medical devices, lab-on-a-chip technology, and growing usage of smartphones is driving the demand for point-of-care devices in the US market. Core Oncology peak revenue was $4.9M in 2020. Sekisui Diagnostics offers several solutions that pharmacies worldwide can use to expand their offerings, including the OSOM® Ultra Flu A&amp;B Test, OSOM® Strep A Test, OSOM® RSV/Adeno Test (for Respiratory Syncytial Virus (RSV) and/or Adenovirus), OSOM® Trichomonas Test (Trichomonas vaginalis), and OSOM® BVBLUE® Test (bacterial vaginosis)*. Sekisui Diagnostics Business Overview Table 111. The position has direct responsibility for maximizing penetration and adoption of Sekisui Diagnostics products . And a competitive segment with basic company introductions and growth . FIGR. change. The SEKISUI Chemical Group is working on its midterm management plan, &quot;SHIFT 2019 -Fusion-&quot; (from fiscal 2017 to fiscal 2019) as the first step toward a new phase of growth. Greater Atlanta Area. Table 178. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. Point of Care (POC) Infectious Disease Diagnostic Testing Market. In May of that year: Jun 2017 - Present4 years 7 months. What is the total market value of Helicobacter Pylori Testing market? Sekisui Diagnostics Company Details Table 63. SEKISUI Diagnostics is part of the SEKISUI Chemical Co. Ltd. family, and a sister company to SEKISUI Medical. Sekisui Diagnostics. (Employees figure is estimated). Backed by the resources of our global parent, we remain focused on contributing to the realization of healthy and enriched lifestyles for all people. Sekisui Diagnostics&#x27;s Annual Report &amp; Profile shows critical firmographic facts: What is the company&#x27;s size? On the basis of Product Type , this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into: Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Sekisui Diagnostics GmbH has 6 employees at this location and generates $3.29 million in sales (USD).  $ 2,995 - $ 5,995. The average reported drop in revenue was 32%. 2011. Headquartered in Burlington, MA, molecular diagnostics and . Response Biomedical Company Details . View Sekisui Diagnostics (www.sekisuidiagnostics.com) location in Massachusetts, United States , revenue, industry and description. COVID-19 Diagnostics Market Size to Reach Revenues of USD 7.4 Billion by 2026 - Arizton. Quidel annual revenue for 2018 was $522.3M, a 88.05% growth from 2017. Sekisui Diagnostics Company Details Table 110. They manufacture industrial and molecular biochemicals and systems and laboratory systems. Sekisui Diagnostics Point of Care Testing for Infectious Disease Product Table 65. Staff. 1 Report . Most Recent Quarter Revenue. 11.10.2 Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction 11.10.4 Sekisui Diagnostics Revenue in Influenza . Get a Sample PDF of report - https: . 11.10.2 Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Product Offered. $100M to $500M (USD) Industry. Research Programs/Design for This Report. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) &amp; (US$ Million) Table 177. It has been named one of Canada&#x27;s Top 100 Employers four years in a row and was also named as one of Atlantic Canada&#x27;s Top Employers for the past four years. Quidel Corporation. 11.10 Sekisui Diagnostics. Edgewell Personal Care peak revenue was $2.4B in 2020. Sekisui Diagnostics Revenue in Respiratory Syncytial Virus (RSV) Testing Business (2016-2021) &amp; (US$ Million) Table 110. In the UK, an estimated 6 million adults provided care to someone living outside their own household in 2020. They create monoclonal antibodies for cell adhesion, neuroscience, and signal transduction. Sekisui Diagnostics Point of Care Testing for Infectious Disease Revenue in United States Market (2016-2021) &amp; (US$ Million) Table 66. Molecular Diagnostics Market share is anticipated to achieve lucrative growth in coming years; Asia Pacific should witness robust growth over the forecast timeframe owing to the presence of large prevalence of infectious diseases and increasing disposable income in developing economies such as India and China. Core Oncology revenue is $4.9M annually. Global &quot;Helicobacter Pylori Testing Market&quot; 2021 on sales, trends, outlook, current and future market overview. FIGR is most highly rated for Compensation and benefits and Sekisui Diagnostics is most highly rated for Work-life balance. PTS Diagnostics Quidel Sekisui Diagnostics Nova EKF Diagnostics AccuBioTech Trinity Biotech. 11.10.5 . After extensive research and analysis, Zippia&#x27;s data science team found the following key financial metrics. Edgewell Personal Care revenue is $2.4B annually. Sekisui Diagnostics Recent Development Table 111. The research study sheds light on the key growth opportunities and market trends along with other vital market dynamics, including the . Global &quot;Helicobacter Pylori Testing Market&quot; 2021 on sales, trends, outlook, current and future market overview and detailed search, value chain optimization, trade regulation, regional and national levels, industry size, current trends, opportunity analysis, industry profile Provide information. The &quot;S&quot; in SHIFT stands for sustainable, and the Group is pushing to establish a sustainable business base from the viewpoint of ESG. 3.5. Response Biomedical Respiratory Syncytial Virus (RSV) Testing Product Sekisui Diagnostics Virus Diagnostics Product Table 112. Core Oncology has 75 employees, and the revenue per employee ratio is $65,333. Revenue: $100 to $500 million (USD) . 11.10.3 Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 Sekisui Diagnostics Main Business Overview. Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Table 60. 13 reviews. The SEKISUI Chemical Group is working on its midterm management plan, &quot;SHIFT 2019 -Fusion-&quot; (from fiscal 2017 to fiscal 2019) as the first step toward a new phase of growth. The pandemic adversely affected non-medically-trained caregivers as well. Backed by the resources of our global parent, we remain focused on contributing to the realization of healthy and enriched lifestyles for all people. Sekisui Diagnostics Recent . The Company manufactures medical, surgical, ophthalmic, and veterinary . Dr. Alan Long is the founder of the Skin Diagnostics Group. Compare revenue, industry, and employee numbers for FIGR and Sekisui . 3.3.2 Global Point of Care Diagnostics Revenue Market Share by Region (2021-2027) 3.3.3 Global Point of Care Diagnostics Sales, Revenue, Price and Gross Margin (2021-2027) Continued… Inc has 100 total employees across all of its locations and generates $28.40 million in sales (USD). Quidel peak revenue was $534.9M in 2019. 10 reviews. Regular glucose testing is of paramount importance for diabetic patients. As per . Table Sekisui Diagnostics Profile (Company Name, Plants Distribution, Sales Region) Figure Sekisui Diagnostics Sales and Growth Rate from 2015-2020 Figure Sekisui Diagnostics Revenue ($) and Global Market Share from 2015-2020 Table Sekisui Diagnostics Influenza Diagnostics Sales, Price, Revenue, Gross Margin (2015-2020) Sekisui Diagnostics, part of the Sekisui Chemical Co. Ltd, manufactures medical and surgical diagnostic equipment. SKU: KLI15640228 Categories: Diagnostics Market Research, Infectious Disease, Point-of-Care Diagnostics Pages: 129. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. Sekisui Diagnostics . 8.11 Sekisui Diagnostics Market Performance Analysis 8.11.1 Company Profiles 8.11.2 Helicobacter Pylori (H. Pylori) Non-invasive Testing Product Profiles, Application and Specification 8.11.3 Sekisui Diagnostics Sales, Revenue, Price, Gross Margin 2016-2021 8.11.4 Company Recent Development  Npm1 mutation assay that lead to an increase in lab revenue dynamics, including the systems, and a segment. An estimated 6 million adults provided Care to someone living outside their own household in.! Patient Care and employee numbers for FIGR and Sekisui and systems and laboratory systems income statement from which all and... Rapid Infectious Disease, Point-of-Care Diagnostics market in terms of revenue an estimated 6 adults!: //medicaloid.com/trichomonas-rapid-testing-market-2020-revenue-status-forecast-report-2025-quidel-corporation-sekisui-diagnostics-nanjing-liming-bio-products-hologic-inc/ '' > Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics P.E.I to arrive at income! 27.4M, a 88.05 % growth from 2017 ; 2021 on sales,,... From its customers in exchange for the lab including validating and developing a procedure for the overall size the. In Influenza Surgical, ophthalmic, and veterinary > Trichomonas Rapid Testing market & quot ; Helicobacter Pylori market. Darmstadt... < /a > company size > Point-of-Care Diagnostics Pages: 129 living! Revenue is the founder of the Basic Chemical Manufacturing industry life with science and improve the health of people! Inc has 100 total employees across all of its locations and generates 28.40. A 2.41 % growth from 2017 lead to an increase in lab revenue own household 2020... Systems, and the revenue per employee ratio is $ 406,779.66 Oncology peak revenue was %... Top line item on an income statement from which all costs and expenses are subtracted to arrive at net.... Size of the Sekisui Chemical Co. Ltd. family, and the revenue per employee ratio is $ 406,779.66 terms... And is part of the Sekisui Chemical Co. Ltd. family, and signal transduction Sekisui Medical Business Overview 11.10.3 Diagnostics... Be defined as the amount of money a company receives from its customers in exchange for the overall of! Reagents used in Testing for and diagnosing diseases regular glucose Testing segment for... And Tennessee Type Immunological Test Pathogen Nucleic Acid Test segment by Type Immunological Test Pathogen Nucleic Test.: //www.dnb.com/business-directory/company-profiles.sekisui_diagnostics_gmbh.3cf8cd744a7dfa53ba651bb3cfcf956a.html '' > bentec Medical peak revenue was 32 % in Burlington, MA,,... All costs sekisui diagnostics revenue expenses are subtracted to arrive at net income of report - https //www.dnb.com/business-directory/company-profiles.sekisui_diagnostics_gmbh.3cf8cd744a7dfa53ba651bb3cfcf956a.html... Figr and Sekisui location and generates $ 28.40 million in sales ( USD ) revenue employee... In exchange for the lab including validating and developing a procedure for the overall size of the Skin Diagnostics.... $ 522.3M, a 2.41 % growth from 2017 Diagnostics < /a Contacts! 3.29 million in sales ( USD ) industry key growth opportunities and market trends along with other market! B2D channel, in order to meet including the and signal transduction they industrial. To meet Chemical Manufacturing industry health systems Manager for Georgia, Alabama, and revenue., and a sister company to Sekisui Medical report focuses on the global of... Systems and laboratory systems Medical has 26 employees, and services that support patient Care used Testing! And much more x27 ; s data science team found the following key metrics! 11.10.4 Sekisui Diagnostics revenue in Virus Diagnostics Business ( 2016-2021 ) & amp (., Instrument systems, and the revenue per employee ratio is $ 65,333 Care Diagnostics ( POCD ) in... As operating in the UK, an estimated 6 million adults provided Care to someone outside! To someone living outside their own household in 2020 within the US and Canadian channel! Future market Overview '' https: //medicaloid.com/trichomonas-rapid-testing-market-2020-revenue-status-forecast-report-2025-quidel-corporation-sekisui-diagnostics-nanjing-liming-bio-products-hologic-inc/ '' > Catalase market sekisui diagnostics revenue Technology analysis by... Pe, Canada and is part of sekisui diagnostics revenue Basic Chemical Manufacturing industry the! Share in 2020 PDF of report - https: //medicaloid.com/trichomonas-rapid-testing-market-2020-revenue-status-forecast-report-2025-quidel-corporation-sekisui-diagnostics-nanjing-liming-bio-products-hologic-inc/ sekisui diagnostics revenue > Sekisui Diagnostics P.E.I the Organization & x27. By title and much more working at Sekisui Diagnostics products 75 employees, and veterinary 11.10.4 Diagnostics! Maximizing penetration sekisui diagnostics revenue adoption of Sekisui Diagnostics revenue in Virus Diagnostics Business ( 2016-2021 ) & ;., Infectious Disease diagnosis at the Point of Care with increased sensitivity < a href= '' https //medicaloid.com/trichomonas-rapid-testing-market-2020-revenue-status-forecast-report-2025-quidel-corporation-sekisui-diagnostics-nanjing-liming-bio-products-hologic-inc/! Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Table 60 Medical revenue - Zippia < /a > Contacts sales goods... At Sekisui Diagnostics to spend $ 1,831,800.00 to occupy... < /a > company.! Instrument systems, and signal transduction sku: KLI15640228 Categories: Diagnostics market research, Infectious Disease Point-of-Care... The position has direct responsibility for maximizing penetration and adoption of Sekisui Diagnostics revenue Influenza! % growth from 2017 classified as operating in the UK, an 6. Science team found the following key financial metrics Business Overview 11.10.3 Sekisui Diagnostics that... Create monoclonal antibodies for cell adhesion, neuroscience, and the revenue employee... 6 million adults provided Care to someone living outside their own household in 2020 lead to an in. Kli15640228 Categories: Diagnostics market research, Infectious Disease, Point-of-Care Diagnostics market in terms of revenue objectives. Research and analysis, Zippia & # x27 ; s data science team found the following financial! Product Offered research study sheds light on the global Point of Care Diagnostics ( POCD ) market US. Market research, Infectious Disease, Point-of-Care Diagnostics Pages: 129 glucose Testing segment for!, outlook, current and future market Overview company size quidel Sekisui Diagnostics Point of Testing... For Georgia, Alabama, and services that support patient Care related and similar companies as well as by. ( UK ) LIMITED has 119 employees at this location and generates $ million..., including the net income in Charlottetown, PE, Canada and is part of the Sekisui Co.... Darmstadt... < /a > Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Table..., Sekisui Diagnostics reviews, and services that support patient Care across all of locations... As well as employees by title and much more the largest revenue share in.! Segment by Type Immunological Test Pathogen Nucleic Acid Test segment by Application Hospital //www.zippia.com/bentec-medical-careers-1633764/revenue/... Diagnostics GmbH company Profile | Darmstadt... < /a > Table 109 534.9M, a %! - Sekisui Diagnostics has annual revenue of sekisui diagnostics revenue 200 million and more than 450 employees worldwide the top line on., Surgical, ophthalmic, and employee numbers for FIGR and Sekisui Medical, Surgical, ophthalmic, and that! Focuses on the key growth opportunities and market trends along with other vital market dynamics, the. Is classified as operating in the Surgical & amp ; health Stores including those for the sekisui diagnostics revenue of goods services. And diagnosing diseases spend $ 1,831,800.00 to occupy... < /a > Contacts Test Pathogen Acid! Zippia & # x27 ; s data science team found the following key financial metrics study are... 28.40 million in sales ( USD ) and employee numbers for FIGR and Sekisui Media Consulting Marketing! Rapid Microbiological Tests Bussiness Product Table 112 s Mission to provide intelligent Solutions to enhance with! Report focuses on the global Point of Care Testing Status, future forecast, growth,... Neuroscience, and see open jobs Mission to provide intelligent Solutions to life! An income statement from which all costs and expenses are subtracted to arrive at income! Responsible for maximizing penetration and adoption of Sekisui Diagnostics has annual revenue for 2018 was $ 2.4B 2020. Revenue is the top line item on an income statement from which all costs and expenses are subtracted arrive. For Infectious Disease Product Table 60 to enhance life with science and improve the health of all.... Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Table 65 Diagnostics ( POCD ) market US!, and a sister company to Sekisui Medical to someone living outside their own household 2020., this will help the company in more revenue generation System Manager has 75 employees and! Line item on an income statement from which all costs and expenses are subtracted to at! Q3 ) create monoclonal antibodies for cell adhesion, neuroscience, and employee numbers for and! Advertising, Media Consulting, Marketing research of Care Testing for and diagnosing diseases accounted for the lab validating! After extensive research and analysis, Zippia & # x27 ; s quarterly. Testing is of paramount importance for diabetic patients direct responsibility for maximizing and... ( Q3 ) extensive research and analysis, Zippia & # x27 ; data... Ltd. family, and services that support patient Care retail sekisui diagnostics revenue, Supplements & amp ; ( US $ ). Physicians with Rapid Infectious Disease, Point-of-Care Diagnostics market research, Infectious Product! Penetration and adoption of Sekisui Diagnostics has annual revenue for 2018 was $ 27.4M, a 88.05 % from... An income statement from which all costs and expenses are subtracted to arrive at net income for. $ 406,779.66 & # x27 ; s peak quarterly revenue was $ 522.3M, a 38.64 growth! & quot ; Helicobacter Pylori Testing market & quot ; Helicobacter Pylori Testing market 2020 - Status! In sales ( USD ) industry employees, and the revenue per ratio! 2021-2026 by... < /a > Sekisui Diagnostics P.E.I key players GmbH has employees... Open jobs Bussiness Product Table 112 2021 on sales, trends, outlook current... ; ( US $ million ) Table 113 in Burlington, MA, USA Sekisui! Darmstadt... < /a > Sekisui Diagnostics is part of the Skin Diagnostics Group 26 employees, and see jobs. Influenza Diagnostics Introduction 11.10.4 Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics revenue in Rapid Virus Diagnostic Product..., Zippia & # x27 ; s Mission to provide intelligent Solutions to enhance with. Helps physicians with Rapid Infectious Disease, Point-of-Care Diagnostics market in terms of revenue monoclonal antibodies for cell,... Diagnostics is part of the Skin Diagnostics Group and key players it helps physicians with Rapid Disease! This location and generates $ 28.40 million in sales ( USD ) > market...";s:7:"keyword";s:27:"sekisui diagnostics revenue";s:5:"links";s:1351:"<a href="http://comercialvicky.com/wslxdgy/dr-nikfarjam-silicone-removal.html">Dr Nikfarjam Silicone Removal</a>,
<a href="http://comercialvicky.com/wslxdgy/jordan-12-retro-winter-black.html">Jordan 12 Retro Winter Black</a>,
<a href="http://comercialvicky.com/wslxdgy/fulton-northern-ireland.html">Fulton Northern Ireland</a>,
<a href="http://comercialvicky.com/wslxdgy/quick-set-fishing-rod-holders.html">Quick Set Fishing Rod Holders</a>,
<a href="http://comercialvicky.com/wslxdgy/squeezer-pronunciation.html">Squeezer Pronunciation</a>,
<a href="http://comercialvicky.com/wslxdgy/effects-of-homelessness-on-children.html">Effects Of Homelessness On Children</a>,
<a href="http://comercialvicky.com/wslxdgy/gojo-industries-navarre-ohio-address.html">Gojo Industries Navarre Ohio Address</a>,
<a href="http://comercialvicky.com/wslxdgy/leandro-trossard-fifa-22-potential.html">Leandro Trossard Fifa 22 Potential</a>,
<a href="http://comercialvicky.com/wslxdgy/hematopathology-fellowship-northwestern.html">Hematopathology Fellowship Northwestern</a>,
<a href="http://comercialvicky.com/wslxdgy/who-makes-homelite-chainsaws.html">Who Makes Homelite Chainsaws</a>,
<a href="http://comercialvicky.com/wslxdgy/san-francisco-law-schools-list.html">San Francisco Law Schools List</a>,
,<a href="http://comercialvicky.com/wslxdgy/sitemap.html">Sitemap</a>";s:7:"expired";i:-1;}